Press Releases

Important milestones in clinical trials, regulatory progress, and significant strides made in addressing the urgent need for effective treatment of suicidal ideation.

Stay tuned—exciting updates are on the horizon. Check back soon for the latest press releases!

Breakthrough status with FDA – Duplicate – [#1] – Duplicate – [#303]

Breakthrough status with FDA – Duplicate – [#1]

Breakthrough status with FDA

Revolutionizing Mental Health Care

GSKB Pharmaceuticals represents a revolutionary step forward in mental health care, investigating a medication specifically designed to confront suicide-related disorders. With a bold vision and innovative science, we aim to save lives, restore hope, and redefine what’s possible in the treatment of one of the most urgent and complex challenges of our time.